Clinical Report: Intense Pulsed Light for Dry Eye

Overview

A recent study demonstrates that intense pulsed light (IPL) therapy significantly improves tear film stability and reduces ocular surface inflammation in patients with dry eye disease (DED). A regimen of three IPL sessions is shown to outperform two sessions in key clinical parameters, suggesting IPL's role as a core strategy in managing evaporative DED.

Background

Dry eye disease (DED) is a common condition that can significantly impact quality of life. Intense pulsed light (IPL) therapy has emerged as a promising treatment, particularly for patients with meibomian gland dysfunction (MGD). Understanding the optimal treatment regimen and the biological mechanisms involved is crucial for enhancing patient outcomes.

Data Highlights

Key Findings

• IPL therapy improves tear film stability and meibomian gland performance.
• Three IPL sessions yield better outcomes than two sessions in key clinical parameters.
• At 12 weeks, NITBUT increased significantly more in the three-session group.
• Only the three-session regimen resulted in a significant rise in the tear biomarker lymphotoxin-alpha (LT-α).
• Both groups showed symptom improvement, but objective measures continued to improve in the three-session group.

Clinical Implications

Clinicians should consider IPL therapy as a primary treatment option for patients with evaporative DED, particularly those with MGD. A regimen of three sessions may provide superior long-term benefits compared to fewer sessions, emphasizing the need for tailored treatment plans.

Conclusion

The findings support the integration of IPL therapy into standard care for DED, highlighting its potential to address both symptoms and underlying biological mechanisms.

References

1. Ophthalmology Management, 2026 -- Adding Interventional DED Treatment to Your Practice
2. Ophthalmology Management, 2015 -- Intense pulsed light and dry eye disease
3. Optometric Management, 2019 -- CLINICAL: Dry Eye
4. TFOS DEWS III: Management and Therapy - ScienceDirect
5. Optometric Management — What's new
6. TFOS DEWS III: Management and Therapy - ScienceDirect
7. Safety and efficacy of a novel intense pulsed light system in patients with meibomian gland dysfunction: a randomized, double-masked, intra-individual controlled study | International Ophthalmology
8. Frontiers | Response of tear cytokines following intense pulsed light combined with meibomian gland expression for treating meibomian gland dysfunction-related dry eye